622 related articles for article (PubMed ID: 27483295)
1. Endocrine Aspects of Environmental "Obesogen" Pollutants.
Nappi F; Barrea L; Di Somma C; Savanelli MC; Muscogiuri G; Orio F; Savastano S
Int J Environ Res Public Health; 2016 Jul; 13(8):. PubMed ID: 27483295
[TBL] [Abstract][Full Text] [Related]
2. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals.
Stel J; Legler J
Endocrinology; 2015 Oct; 156(10):3466-72. PubMed ID: 26241072
[TBL] [Abstract][Full Text] [Related]
3. [Endocrine disruptors: A missing link in the pandemy of type 2 diabetes and obesity?].
Chevalier N; Fénichel P
Presse Med; 2016 Jan; 45(1):88-97. PubMed ID: 26655260
[TBL] [Abstract][Full Text] [Related]
4. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
Yilmaz B; Terekeci H; Sandal S; Kelestimur F
Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
[TBL] [Abstract][Full Text] [Related]
5. Endocrine disruptors: from endocrine to metabolic disruption.
Casals-Casas C; Desvergne B
Annu Rev Physiol; 2011; 73():135-62. PubMed ID: 21054169
[TBL] [Abstract][Full Text] [Related]
6. Endocrine disruptors: new players in the pathophysiology of type 2 diabetes?
Chevalier N; Fénichel P
Diabetes Metab; 2015 Apr; 41(2):107-15. PubMed ID: 25454091
[TBL] [Abstract][Full Text] [Related]
7. Endocrine disruptors and obesity.
Heindel JJ; Newbold R; Schug TT
Nat Rev Endocrinol; 2015 Nov; 11(11):653-61. PubMed ID: 26391979
[TBL] [Abstract][Full Text] [Related]
8. Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants-A Review.
Kowalczyk M; Piwowarski JP; Wardaszka A; Średnicka P; Wójcicki M; Juszczuk-Kubiak E
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674599
[TBL] [Abstract][Full Text] [Related]
9. Impact of environmental endocrine disrupting chemicals on the development of obesity.
Newbold RR
Hormones (Athens); 2010; 9(3):206-17. PubMed ID: 20688618
[TBL] [Abstract][Full Text] [Related]
10. Obesogens: an emerging threat to public health.
Janesick AS; Blumberg B
Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
[TBL] [Abstract][Full Text] [Related]
11. Environmental Endocrine-Disrupting Chemical Exposure: Role in Non-Communicable Diseases.
Kumar M; Sarma DK; Shubham S; Kumawat M; Verma V; Prakash A; Tiwari R
Front Public Health; 2020; 8():553850. PubMed ID: 33072697
[TBL] [Abstract][Full Text] [Related]
12. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
[TBL] [Abstract][Full Text] [Related]
13. Environmental exposures to endocrine disrupting chemicals (EDCs) and their role in endometriosis: a systematic literature review.
Sirohi D; Al Ramadhani R; Knibbs LD
Rev Environ Health; 2021 Mar; 36(1):101-115. PubMed ID: 32903210
[TBL] [Abstract][Full Text] [Related]
14. Impact of endocrine disrupting chemicals on onset and development of female reproductive disorders and hormone-related cancer.
Scsukova S; Rollerova E; Bujnakova Mlynarcikova A
Reprod Biol; 2016 Dec; 16(4):243-254. PubMed ID: 27692877
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome and environmental toxins.
Rutkowska AZ; Diamanti-Kandarakis E
Fertil Steril; 2016 Sep; 106(4):948-58. PubMed ID: 27559705
[TBL] [Abstract][Full Text] [Related]
16. The OBELIX project: early life exposure to endocrine disruptors and obesity.
Legler J; Hamers T; van Eck van der Sluijs-van de Bor M; Schoeters G; van der Ven L; Eggesbo M; Koppe J; Feinberg M; Trnovec T
Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1933S-1938S. PubMed ID: 21543539
[TBL] [Abstract][Full Text] [Related]
17. Disease burden attributable to endocrine-disrupting chemicals exposure in China: A case study of phthalates.
Cao Y; Li L; Shen K; Liu J
Sci Total Environ; 2019 Apr; 662():615-621. PubMed ID: 30699382
[TBL] [Abstract][Full Text] [Related]
18. Agrochemicals and obesity.
Ren XM; Kuo Y; Blumberg B
Mol Cell Endocrinol; 2020 Sep; 515():110926. PubMed ID: 32619583
[TBL] [Abstract][Full Text] [Related]
19. Urinary levels of endocrine-disrupting chemicals, including bisphenols, bisphenol A diglycidyl ethers, benzophenones, parabens, and triclosan in obese and non-obese Indian children.
Xue J; Wu Q; Sakthivel S; Pavithran PV; Vasukutty JR; Kannan K
Environ Res; 2015 Feb; 137():120-8. PubMed ID: 25531816
[TBL] [Abstract][Full Text] [Related]
20. Significance of and Challenges in Regulating Endocrine Disruptors - How Regulators and Industry Can Conquer?
Dhiman SK; Dureja H
Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1664-1681. PubMed ID: 32504507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
